OMX-0407 a Spectrum Selective Kinase Inhibitor Shows Preclinical & Clinical Efficacy in Angiosarcoma
Time: 4:30 pm
day: Conference Day 1
Details:
- Demonstrating striking anti-tumour efficacy in a rare indication PDX of an Angiosarcoma with a comprehensive mode of action analysis
- Translating research into the first clinical findings with one responder patient in a Ph1a study
